Asset sale Announced Sponsor buyer
Lone Star Funds acquisition of Lonza Capsules & Health Ingredients division
Announced Mar 2026
Advisers
Lonza Capsules & Health Ingredients division
Target
Not disclosed
Lone Star Funds
Acquirer
- Legal adviser
- Kirkland & Ellis

Team: Jacob Traff, James Hunn, David Higgins, Jamie Gordon, Khadar Jama, Ben Zelouf, Ben Fuhrmann, Daniel Borg, Sam Sherwood, Alex Bond, Cristina Poon, Alma Chan, Ashley Bannister, Alex Doust, André Duminy, Corina Demeter-Olive, Samantha Bradley, Shareen Dhillon, Ceinwen Rees, Joseph Tootle, Michael Akpomiemie, Chloe Rowan, Yewande Ford, Tim Volkheimer
- Target
- Lonza Capsules & Health Ingredients division
- Acquirer
- Lone Star Funds
- Seller
- Lonza Group AG
- Buyer based in
- United States
- Seller based in
- Switzerland
- Sector
- Pharmaceutical Manufacturing
- Tags
- Pharmaceutical Manufacturing, Life Sciences, Food Ingredients
In the league tables
Similar deals
- Aksìa SGR acquisition of Valsa Group Nov 2026 · Bakery
- Invex Therapeutics acquisition of Rekover Therapeutics Oct 2026 · Healthcare
- Element Biosystems acquisition of Standard BioTools Mass Cytometry business Sep 2026 · US$5.5m · Life Sciences
- Webster Equity Partners acquisition of Lifecore Biomedical Sep 2026 · US$664m · Pharma Services
- TPG acquisition of Agilex Biolabs Sep 2026 · US$114m · Healthcare